The FDA has announced a new warning for the flu drug Tamiflu. The new warning notes reports of self-injury and delirium in flu patients taking Tamiflu, mainly among children in Japan.
The FDA knows of 103 reported cases – 95 from Japan, five from the U.S., and three from other countries. Sixty of the 103 cases featured delirium with prominent behavioral disturbance such as panic attack, hallucinations, and convulsions; only one of those cases occurred in the U.S.
“People with the flu, particularly children, may be at an increased risk of self-injury and confusion shortly after taking Tamiflu and should be closely monitored for signs of unusual behavior,” states Tamiflu’s new warning.